Replies to post #118185 on Amarantus Bioscience Holdings Inc (AMBS)

[Alapis]

x-times they current market cap...if approved it's worth several billions

[Skeetz99]

The market will value Pharma./Biotech related revenue at or around 6x (so it depends on how close and how confident the market is on the revenue projection and how near its toward approval/commercialization.

1 billion in revenue equals 6 billion market cap. Also, you must include all remaining assets as well. If Mgt. executes properly on ESS; they sky is the limit (of course, lets take it one day at a time).

[redspeed]

Back in 2010 when Regenicin announced the deal with Lonza the stock was at $2.20 and a market cap of $185K. Since then there is DoD backing, ODD, IND, Phase 2 trial starting, other orphans, potential PRV(s) valued at $300M each, etc.

Additionally, an award from ASPR or purchase by BARDA down the road would send this through the roof where it would be too late to get in. GC mentioned on the call they presented in May and will come back next month with more data.